Cureus | Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
Safety Profile - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Transition of Anticoagulants 2014
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect
Cureus | Clinical Outcomes and Costs of Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Inpatients: A Cross-Sectional Study
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Transition of Anticoagulants 2016
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Anticoagulants | Health Navigator NZ
Dose of XARELTO for Switching From Another Anticoagulant During Initial DVT or PE Treatment
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial - The Lancet
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology | Revista Española de Cardiología
Recommendations for Switching to and From Rivaroxaban 9 | Download Table
Guideline for the Prescribing of Novel Oral Anticoagulants (NOACs): Dabigatran (Pradaxa ), Rivaroxaban (Xarelto ), Apixaban (Eliquis ) - PDF Free Download
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week - ScienceDirect
Antithrombotic Management of Venous Thromboembolism: JACC Focus Seminar - ScienceDirect
Xarelto® - Responsible Use
Guidance on converting between anticoagulants
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
Apixaban starting dose after 1 week LMWH therapy (PE or DVT)? | ResearchGate
Aspirin and an oral anticoagulant – can they be used together? - NPS MedicineWise
RBCP - Cost comparison between enoxaparin and new oral anticoagulants dabigatran and rivaroxaban in venous thromboembolism prophylaxis
